My research is focused on developing and applying mass spectrometry techniques to support biomarker and drug discovery programs. Currently, I am applying chemo-proteomics technology to study the selectivity and specificity of the kinase inhibitors, as well as to gain insights into the mechanism of action of drug inhibitors. 

I joined Biogen as a member of the Proteomics group in January of 2012, prior to that I received my Ph.D. at the University of Connecticut, where I worked on developing high-throughput mass spectrometry based assays for quantifying therapeutic biomarkers for Cystic Fibrosis treatment.


  • Ph.D., University of Connecticut, Storrs, CT - 2012
  • B.S., Central Connecticut State University, New Britain, CT - 2005

Selected Publications

See more scientists